91 related articles for article (PubMed ID: 1313743)
1. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study.
Têtu B; Lacasse B; Bouchard HL; Lagacé R; Huot J; Landry J
Cancer Res; 1992 Apr; 52(8):2325-8. PubMed ID: 1313743
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus.
Kawanishi K; Shiozaki H; Doki Y; Sakita I; Inoue M; Yano M; Tsujinaka T; Shamma A; Monden M
Cancer; 1999 Apr; 85(8):1649-57. PubMed ID: 10223556
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis.
Le Doussal V; Coindre JM; Leroux A; Hacene K; Terrier P; Bui NB; Bonichon F; Collin F; Mandard AM; Contesso G
Cancer; 1996 May; 77(9):1823-30. PubMed ID: 8646680
[TBL] [Abstract][Full Text] [Related]
4. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
[TBL] [Abstract][Full Text] [Related]
5. Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers.
Storm FK; Mahvi DM; Gilchrist KW
Urology; 1993 Oct; 42(4):379-82. PubMed ID: 8212437
[TBL] [Abstract][Full Text] [Related]
6. Malignant fibrous histiocytoma of the extremity.
Salo JC; Lewis JJ; Woodruff JM; Leung DH; Brennan MF
Cancer; 1999 Apr; 85(8):1765-72. PubMed ID: 10223571
[TBL] [Abstract][Full Text] [Related]
7. Results of surgery for malignant fibrous histiocytomas of soft tissue.
Matsumoto S; Ahmed AR; Kawaguchi N; Manabe J; Matsushita Y
Int J Clin Oncol; 2003 Apr; 8(2):104-9. PubMed ID: 12720103
[TBL] [Abstract][Full Text] [Related]
8. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas.
Engellau J; Anderson H; Rydholm A; Bauer HC; Hall KS; Gustafson P; Akerman M; Meis-Kindblom J; Alvegård TA; Nilbert M;
Cancer; 2004 May; 100(10):2233-9. PubMed ID: 15139069
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy for high grade malignant fibrous histiocytoma of bone.
Bacci G; Picci P; Mercuri M; Bertoni F; Ferrari S
Clin Orthop Relat Res; 1998 Jan; (346):178-89. PubMed ID: 9577426
[TBL] [Abstract][Full Text] [Related]
10. [Malignant fibrous histiocytoma. An attempt at a histo-clinical correlation in 21 cases].
Etienne-de Marignac L; Kapanci Y
Schweiz Med Wochenschr; 1982 Dec; 112(51):1881-8. PubMed ID: 6298932
[TBL] [Abstract][Full Text] [Related]
11. Analysis of prognostic factors and chemotherapy of malignant fibrous histiocytoma of soft tissue: a preliminary report.
Shinjo K
Jpn J Clin Oncol; 1994 Jun; 24(3):154-9. PubMed ID: 8007425
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study.
Têtu B; Brisson J; Landry J; Huot J
Breast Cancer Res Treat; 1995; 36(1):93-7. PubMed ID: 7579511
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic examination of heat shock proteins (HSP 27, HSP 70, and HSP 90) in medulloblastoma.
Hauser P; Hanzély Z; Jakab Z; Oláh L; Szabó E; Jeney A; Schuler D; Fekete G; Bognár L; Garami M
J Pediatr Hematol Oncol; 2006 Jul; 28(7):461-6. PubMed ID: 16825994
[TBL] [Abstract][Full Text] [Related]
14. Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases.
Furusato E; Valenzuela IA; Fanburg-Smith JC; Auerbach A; Furusato B; Cameron JD; Rushing EJ
Hum Pathol; 2011 Jan; 42(1):120-8. PubMed ID: 21056898
[TBL] [Abstract][Full Text] [Related]
15. [Malignant fibrous histiocytoma. Prognostic value of the histological findings].
Donhuijsen K; Kroll M; Krause U
Dtsch Med Wochenschr; 1986 Jan; 111(2):46-51. PubMed ID: 3000721
[TBL] [Abstract][Full Text] [Related]
16. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
17. Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome.
Costa MJ; Weiss SW
Am J Surg Pathol; 1990 Dec; 14(12):1126-32. PubMed ID: 2174650
[TBL] [Abstract][Full Text] [Related]
18. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
[TBL] [Abstract][Full Text] [Related]
20. The expression and prognostic significance of bone morphogenetic protein-2 in patients with malignant fibrous histiocytoma.
Asano N; Yamakazi T; Seto M; Matsumine A; Yoshikawa H; Uchida A
J Bone Joint Surg Br; 2004 May; 86(4):607-12. PubMed ID: 15174563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
